This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Research over more than 2 decades indicates anxiety and depression are common among people with epilepsy and associated with an increased risk of poor outcomes, including suicide. Active surveillance data in the United States show that the annual suicide mortality rate in people with epilepsy was 22% higher than in the general population.1 Other population-based case-control studies have demonstrated 3 times or higher risk of suicide among those with epilepsy than controls.2 A bidirectional relation has been documented in which these patients have an increased risk of suicidality before and after the onset of epilepsy, with suicide risk being highest shortly after epilepsy onset.2,3 These findings have led to calls for neurologists to identify and manage depression and anxiety in these patients, including an AAN quality measure for screening anxiety and depression at every clinic visit,4 and a recently published International League Against Epilepsy practice recommendation for depression management in epilepsy.5
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 508
- Received November 15, 2022.
- Accepted in final form December 6, 2022.
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
